Recall Z-0278-2021— ICU Medical, Inc.

Class II · Terminated

Class II FDA medical device recall by ICU Medical, Inc., initiated 2020-07-06, terminated 2023-05-11. FDA's recall record names no specific 510(k) clearance for this event. Product: 5.5" (14 cm) Appx 0.28 ml, Smallbore Ext Set w/NanoClave, Clamp, Luer Lock. 1 unit per pouch, 50 multivac pouches per case. UDI:(01)10887709077758(17)250101(30)50(10)4603285;(01)10887709077758(17)250101(30)50(10)4603285; (01)10887709077758(17)250101(30)50(10)4630700; (01)10887709077758(17)250301(30)50(10)4749870; (01)10887709077758(17)241201(30)50(10)4514843; (01)10887709077758(17)241201(30)50(10)4549093; (01)10887709077758(17)250101(30)50(10)4558478; (01)10887709077758(17)250201(30)50(10)4724850; (01)10887709077758(17)250201(30)50(10)4734400. The Intravascular Administration Set is a single use, sterile, non-pyrogenic device which provides access for the administration of fluids from a container to a patient's vascular system through the administration set's needle or catheter (which is inserted into a vein).. Reason: Identification of a potential manufacturing defect on the internal surface of the NanoClave within specific lots of NanoClave sets, which may inhibit a proper seal with the NanoClave spike..

Recalling firm
ICU Medical, Inc.
Classification
Class II
Status
Terminated
Initiated
2020-07-06
Terminated
2023-05-11
Firm location
San Clemente, CA, United States

Product description

5.5" (14 cm) Appx 0.28 ml, Smallbore Ext Set w/NanoClave, Clamp, Luer Lock. 1 unit per pouch, 50 multivac pouches per case. UDI:(01)10887709077758(17)250101(30)50(10)4603285;(01)10887709077758(17)250101(30)50(10)4603285; (01)10887709077758(17)250101(30)50(10)4630700; (01)10887709077758(17)250301(30)50(10)4749870; (01)10887709077758(17)241201(30)50(10)4514843; (01)10887709077758(17)241201(30)50(10)4549093; (01)10887709077758(17)250101(30)50(10)4558478; (01)10887709077758(17)250201(30)50(10)4724850; (01)10887709077758(17)250201(30)50(10)4734400. The Intravascular Administration Set is a single use, sterile, non-pyrogenic device which provides access for the administration of fluids from a container to a patient's vascular system through the administration set's needle or catheter (which is inserted into a vein).

Reason for recall

Identification of a potential manufacturing defect on the internal surface of the NanoClave within specific lots of NanoClave sets, which may inhibit a proper seal with the NanoClave spike.

Data sourced from openFDA. This site is unofficial and independent of the FDA.